Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial microbiome refers to the collective community of all bacterial species inhabiting a particular environment—most commonly discussed in reference to human body sites such as the gut, skin, oral cavity, etc.[1][4]. This ecosystem plays essential roles in digestion, metabolism, immune system development and regulation, protection against pathogens through colonization resistance, synthesis of vitamins/metabolites important for host health—and its disruption has been linked to numerous diseases including infections, inflammatory conditions like IBD and allergies,[2][3], metabolic disorders,[7], cancer,[6], neurological conditions,[6], among others. While individual bacterial strains within this community can be considered therapeutic targets—for example by using probiotics or engineered commensals—the "bacterial microbiome" itself is not a single molecular target like an enzyme or receptor. Instead it represents an ecological entity whose overall composition/function can be modulated therapeutically using approaches such as fecal transplantation,[9], probiotics/prebiotics,[9], phage therapy targeting specific members,[2], synthetic biology-driven engineering,[3]. Because it is not a discrete molecule/protein/receptor/transporter/enzyme/transcription factor/etc., listing it as a drug target is scientifically inaccurate. In summary: The term "bacterial microbiome" describes an entire living ecosystem rather than an individual molecular target. It should not be classified alongside canonical drug targets such as receptors or enzymes. --- Key points regarding structured data extraction: • The entry “Bacterial microbiome” does not represent a canonical therapeutic target but rather an ecological concept encompassing many potential targets. • If you require information about specific druggable components within this ecosystem—such as particular bacterial strains/species/enzymes/receptors—those should be specified individually. • For structured databases focused on molecular targets suitable for pharmacological intervention (“target” meaning receptor/enzyme/etc.), “Bacterial microbiome” would generally be flagged as incorrect/inapplicable.
Mechanisms depend on intervention but may include: - Restoration of microbial balance via colonization with beneficial species/probiotics [9] - Suppression or elimination of pathogenic species via phages or engineered microbes [2] - Modulation of immune responses through microbial metabolites and cell signaling [3][6]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial microbiome.